Document is current
Any future updates will be listed below
-
Authors
Higa, Nikki https://orcid.org/0000-0003-3236-8929
Limb, Audrey
Hennes, Valerie
Rivera, Andrés
Nevarez, Rafael
Kolatkar, Anand https://orcid.org/0000-0002-8621-1073
Tweed, Carol K.
Riker, Adam I.
Lee, Young
Tafra, Lorraine
Perkins, Jeremy G.
Shriver, Craig D. https://orcid.org/0000-0001-8993-5811
Kuhn, Peter
Hicks, James https://orcid.org/0000-0001-5353-4338
-
Funding
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-16-189, BCRF-18-089, BCRF-16-189, BCRF-18-089)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (5P30CA014089-40, 5P30CA014089-40)
- License Information
-
More Information
Article History
Received: 29 October 2024
Accepted: 10 July 2025
First Online: 24 July 2025
Competing interests
: P.K. and J.H. hold and receive royalties from Epic Sciences for licensed technology. Epic Sciences and the University of Southern California, USC Michelson Center (P.K. and J.H.), have signed a sponsored research agreement to advance next-generation liquid biopsy technology for precision oncology. All other authors have no conflicts to report.
